Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone
Joint Authors
Staples, Laura
Milder, Tamara
Choi, Philip Young-Ill
Source
Issue
Vol. 2017, Issue 2017 (31 Dec. 2017), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2017-09-27
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
We present the case report of a patient with severe polycythaemia associated with tibolone.
In our 65-year-old postmenopausal patient who initially presented with haemoglobin 203 g/L [115–160] and haematocrit 0.63 [0.32–0.47], the cessation of tibolone, a synthetic hormone replacement therapy, led to a dramatic and sustained resolution of this patient’s polycythaemia to normal haematological values.
Tibolone possesses oestrogenic, androgenic, and progestogenic properties.
Tibolone therapy may be an infrequently recognized contributor towards polycythaemia in postmenopausal patients presenting to haematology clinics.
American Psychological Association (APA)
Staples, Laura& Milder, Tamara& Choi, Philip Young-Ill. 2017. Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone. Case Reports in Hematology،Vol. 2017, no. 2017, pp.1-2.
https://search.emarefa.net/detail/BIM-1145815
Modern Language Association (MLA)
Staples, Laura…[et al.]. Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone. Case Reports in Hematology No. 2017 (2017), pp.1-2.
https://search.emarefa.net/detail/BIM-1145815
American Medical Association (AMA)
Staples, Laura& Milder, Tamara& Choi, Philip Young-Ill. Polycythaemia Secondary to Hormone Replacement Therapy with Tibolone. Case Reports in Hematology. 2017. Vol. 2017, no. 2017, pp.1-2.
https://search.emarefa.net/detail/BIM-1145815
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1145815